NCT05703243View on ClinicalTrials.gov

"Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting (DINOSAur II)"

UnknownOBSERVATIONAL

Enrollment

572

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2025

Conditions

Stage III Solid TumorsStage IV Solid Tumors

Interventions

DIAGNOSTIC_TEST

Comprehensive liquid molecular panel test

Lab test

OTHER

EORTC QLQ-30

Quality of life questionnaire

Trial Locations (1)

91206

RECRUITING

Adventist Health Glendale, Glendale

Sponsors

Collaborators (1)

Guardant Health, Inc.

All Listed Sponsors

collaborator

Guardant Health, Inc.

INDUSTRY

lead

Glendale Adventist Medical Center d/b/a Adventist Health Glendale

OTHER